Titlebook: Management of Hematological Cancer in Older People; Ulrich Wedding,Riccardo A. Audisio Book 2015 Springer-Verlag London 2015 Geriatric.Ger

Obscure

BUDGE

Indolent Lymphomas in Older Patients,-go” and partially “slow-go” patients). In patients with relapse, but also in frail patients, there are many options available ranging from different rituximab-containing chemotherapy regimens, rituximab monotherapy, radioimmunotherapy, local radiotherapy or oral drugs like chlorambucil, cyclophosph

無辜

The Challenge of Treating Elderly Patients with Mantle Cell Lymphoma,fundamental to classify these patients in geriatric categories, objectively identifying those able to receive a chemotherapy aiming at long term control of the disease and patients appropriate only for a palliative therapy, primarily mitigating lymphoma symptoms. Therefore, treatment of elderly pati

接觸

Hodgkin Lymphoma in the Elderly,vious chemotherapy directed approaches, summarises the results of more recent chemotherapeutic approaches, and finally examines the encouraging recent results incorporating targeted biological approaches which may ultimately deliver improved outcomes for the elderly patient affected with this diseas

Exposition

,Diffuse Large B-Cell Non-Hodgkin’s Lymphoma (DLBCL- NHL),75 years of age, incidence rates have doubled (50–100 per 100,000) since 1975. Thus DLBCL is predominantly a disease of older individuals, with a median age of diagnosis at approximately 70 years of age. As demographic changes result in an increasing number of older people the occurrence of NHL in t

豎琴

Geriatric Assessment,f Daily Living, and geriatric syndromes. Two general models have also been constructed to predict tolerance to chemotherapy. Future trials should integrate and compare these assessments as correlates or stratification tools in order to build on the early results already available.

不透明

依法逮捕

Ordnance

分貝

Hematological Malignancies in the Elderly: The Epidemiological Perspective,aged 70 or more years, representing the 45 % of total cases, equally divided into two sexes. The most these malignancies is closely linked to age and incidence rates increased exponentially after 50 years of age..Aetiology of hematological tumours is largely unknown. However the basic causal mechani